International Journal of Pediatric Otorhinolaryngology
Volume 67, Issue 1 , Pages 43-51, January 2003

Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. 3 days azitromycin

  • Fatma Oğuz

      Affiliations

    • Institute of Child Health, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Present address: Göksu Evleri Çiğdem Çıkmazı sok., B-105-B Anadoluhisari-Beykoz, Istanbul, Turkey. Tel./fax: +90-212-531-0529
  • ,
  • Emin Ünüvar

      Affiliations

    • Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Yusufhan Süoğlu

      Affiliations

    • Department of Otorhynolaryngology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Burak Erdamar

      Affiliations

    • Department of Otorhynolaryngology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Gülnur Dündar

      Affiliations

    • Pakize Tarzi Microbiology Laboratory, Turkey
  • ,
  • Sami Katircioğlu

      Affiliations

    • Department of Otorhynolaryngology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Müjgan Sıdal

      Affiliations

    • Institute of Child Health, Istanbul University, Istanbul, Turkey

Received 1 May 2002; received in revised form 19 September 2002; accepted 20 September 2002.

Abstract 

Backgrounds: Acute otitis media (AOM) is a common childhood infection that is frequently treated by antibiotics. There are no prospective and comprehensive trials evaluating childhood AOM for etiologic pathogens and resistance pattern in Turkey. The aims of the study were to determine the bacterial etiologies and resistance patterns, and identify the efficacy and the relapse rates of 3 days of azitromycin and 10 days of cefaclor therapy in AOM. Methods: This prospective, randomized, single-blind, open study was carried out in 78 cases of AOM. Mean age was 30.7±27 months. Tympanocentesis and aspiration of middle ear fluid (MEF) were used to obtain purulent material from the middle ear. Group 1 consisted of the cases (n=41) on azitromycin therapy and Group 2 (n=37) on cefaclor. Dosage of azitromycin was 10 mg/kg per day for 3 days and cefaclor 40 mg/kg per day for 10 days. The patients were evaluated on days 3–5 (second visit), day 10 (third visit), and day 30 (fourth visit) during follow-up. Results: A total of 50 species were isolated from 44 of 78 cases from which materials were obtained (44/78; 56.4%). Most frequently isolated microorganism was Streptococcus pneumoniae (n=18; 36%), followed by Haemophilus influenzae (n=11; 22%), S. aureus (n=9; 18%), Moraxella catarrhalis (n=4; 8%), and group A beta-hemolytic streptococcus (GAS, n=4; 8%). Enterococcus faecalis was isolated from three cases and H. parainfluenzae from one. Penicillin and amoxicillin resistances of bacteria were found to be 40 and 36%, respectively. The frequency of penicillin and amoxicillin resistance in ≤24-month age group was 59 and 66.6%, respectively. The patients did not demonstrate significant differences in terms of cure rate on the third to fifth day (Group 1: 32.5%; Group 2: 36.4%), 10th day (Group 1: 76.9%; Group 2: 84.8%), and on 30th day (Group 1: 91.3%; Group 2: 81.8%). There were no significant differences with respect to side effects, relapse, and re-infection rate between the two groups. Conclusion: In more than half of the AOM cases, bacteria were isolated from MEF and most frequently isolated organisms were S. pneumoniae, H. influenzae, and S. aureus. Three-day azitromycin therapy was as effective as 10-day cefaclor therapy.

Keywords: Acute otitis media, Children, Etiology, Infection, Treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-5876(02)00360-9

International Journal of Pediatric Otorhinolaryngology
Volume 67, Issue 1 , Pages 43-51, January 2003